UK Biotech Circassia Moves Into Asthma With Two Acquisitions – Wall Street Journal (blog)


Wall Street Journal (blog)

UK Biotech Circassia Moves Into Asthma With Two Acquisitions
Wall Street Journal (blog)
Allergy and asthma are natural bedfellows: That's the rationale behind Circassia Pharmaceuticals PLC's acquisition spree announced Friday. The Oxford, England, biotech, which is developing vaccines for a range of allergies, has bought Swedish-listed …
UK's Circassia buys two asthma-focused firms for up to $377 millionReuters
Circassia Pharma buys two asthma-focussed companiesReuters UK
Circassia In Share Sale To Fund GBP239 Million In Acquisitions (ALLISS)London South East
Proactive Investors UK –Insider Media –Stock Market Wire
all 9 news articles »

View full post on asthma – Google News